⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GNLX News
Genelux Corporation Common Stock
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
globenewswire.com
GNLX
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
globenewswire.com
GNLX
Attovia Therapeutics Appoints John W. Smither to Board of Directors
globenewswire.com
MBX
ARQT
NAMS
GNLX
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
globenewswire.com
GNLX
Form 8-K
sec.gov
GNLX
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
globenewswire.com
GNLX
Form 8-K
sec.gov
GNLX
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
GNLX
Genelux Corporation to Participate in Upcoming Conferences
globenewswire.com
GNLX
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
globenewswire.com
GNLX